BOB体育

Skip to main content
(352) 733-0111

Jonathan A Chatzkel, MD

Cancer Specialist (Oncologist), Hematology and Oncology Specialist

Photo of Jonathan A Chatzkel
(352) 733-0111 MyUFHealth

Research at a glance

Top areas of exploration

  • Neoplasms , 3 publications
  • Carcinoma, Renal Cell , 2 publications
  • Kidney Neoplasms , 2 publications
  • Poly(ADP-ribose) Polymerase Inhibitors , 1 publications

Research activity

15 publications

167 citations

Why is this important?

Active clinical trials

My publications

15 publications

2024

Approaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the Clinic.

Research and reports in urology

鈥�

2024

Cecal Metastasis of Clear Cell Renal Cell Carcinoma After Previous Nephrectomy.

ACG case reports journal

鈥�

2024

Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.

JCO precision oncology

鈥�

2023

A nurse-led intervention in patients with newly diagnosed cancer and Type 2 diabetes: A pilot randomized controlled trial feasibility study.

Cancer medicine

鈥�

2022

Atezolizumab plus tivozanib for immunologically cold tumor types: the聽IMMCO-1 trial.

Future oncology (London, England)

鈥�